| Autor: |
Arnold LM; Biological Psychiatry Program, University of Cincinnati Medical Center, Ohio 45267-0559, USA. arnoldm@email.uc.edu, Mutasim DF, Dwight MM, Lamerson CL, Morris EM, McElroy SL |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of clinical psychopharmacology [J Clin Psychopharmacol] 1999 Feb; Vol. 19 (1), pp. 15-8. |
| DOI: |
10.1097/00004714-199902000-00005 |
| Abstrakt: |
The purpose of this study was to examine the safety and efficacy of fluvoxamine in the treatment of psychogenic (neurotic) skin excoriation. Fourteen subjects with psychogenic excoriation were given fluvoxamine in a 12-week, open-label trial after completion of the Structured Clinical Interview for DSM-IV. All subjects met DSM-IV criteria for at least one comorbid psychiatric disorder, with mood disorder the most common. Most subjects' excoriation had features of an impulse control disorder. Both completers (N = 7) and the entire group had significant improvement on the modified Yale-Brown Obsessive Compulsive Scale but no improvement on the Hamilton Rating Scale for Depression. In the self-report data, the seven completers had significant reduction in behaviors involving the skin (e.g., scratching, picking, gouging, or squeezing) and in global assessment of symptoms. Endpoint analysis of all 14 subjects' self-report data demonstrated significant improvement in the presence of skin sensations, skin appearance and lesions, behaviors involving the skin, control over skin behavior, and global assessment. The results of this preliminary open trial suggest that fluvoxamine may be effective in reducing psychogenic excoriation, and this effect seems to be independent of mood. Controlled studies are needed to confirm these findings. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
